BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25142637)

  • 1. Population access to rotavirus vaccination in industrialized countries: lessons learnt from current experience.
    Weil-Olivier C; Millier A; Toumi M; Trichard M
    Expert Rev Vaccines; 2014 Nov; 13(11):1405-17. PubMed ID: 25142637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus vaccination in Central American children.
    Ulloa-Gutierrez R; Avila-Aguero ML
    Expert Rev Vaccines; 2014 Jun; 13(6):687-90. PubMed ID: 24702467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus vaccination: a concise review.
    Vesikari T
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():57-63. PubMed ID: 22882248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population access to new vaccines in European countries.
    Blank PR; Schwenkglenks M; Sardos CS; Patris J; Szucs TD
    Vaccine; 2013 Jun; 31(27):2862-7. PubMed ID: 23632307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
    Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of rotavirus vaccines in Asia--are there lessons to be learnt?
    Mirzayeva R; Steele AD; Parashar UD; Zaman K; Neuzil KM; Nelson EA
    Vaccine; 2009 Nov; 27 Suppl 5():F120-9. PubMed ID: 19931711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus vaccines in Belgium: policy and impact.
    Braeckman T; Van Herck K; Raes M; Vergison A; Sabbe M; Van Damme P
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S21-4. PubMed ID: 21183836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: which key messages in light of a new immunization program?
    Morin A; LemaƮtre T; Farrands A; Carrier N; Gagneur A
    Vaccine; 2012 Sep; 30(41):5921-7. PubMed ID: 22858556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
    Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
    Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
    Patel MM; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
    Rheingans R; Atherly D; Anderson J
    Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
    Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
    Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction.
    Linhares AC; Justino MC
    Expert Rev Vaccines; 2014 Jan; 13(1):43-57. PubMed ID: 24308577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccines WHO position paper: January 2013 - Recommendations.
    Vaccine; 2013 Dec; 31(52):6170-1. PubMed ID: 23746456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework.
    Carvalho N; Jit M; Cox S; Yoong J; Hutubessy RCW
    Pharmacoeconomics; 2018 Jan; 36(1):79-90. PubMed ID: 28905279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus vaccines: considerations for successful implementation in Europe.
    Van Damme P; Van der Wielen M; Ansaldi F; Desgrandchamps D; Domingo JD; Sanchez FG; Gray J; Haditsch M; Johansen K; Lorgelly P; Lorrot M; Parez N; Reschke V; Rose M
    Lancet Infect Dis; 2006 Dec; 6(12):805-12. PubMed ID: 17123900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing rotavirus vaccination in Asia.
    Santosham M; Nelson EA; Bresee JS
    Vaccine; 2007 Nov; 25(44):7711-6. PubMed ID: 17881099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the introduction of rotavirus vaccine--Latin America and the Caribbean, 2006-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1611-4. PubMed ID: 22129995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promise of immunisation against rotavirus.
    Marlow RD; Finn A
    Arch Dis Child; 2012 Aug; 97(8):736-40. PubMed ID: 22611059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating and comparing the clinical and economic impact of paediatric rotavirus vaccination in Turkey using a simple versus an advanced model.
    Bakir M; Standaert B; Turel O; Bilge ZE; Postma M
    Vaccine; 2013 Jan; 31(6):979-86. PubMed ID: 23219433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.